EN | RU
EN | RU

Help Support

Back

Zoledronic acid and denosumab proved to be as effective as teriparatide to prevent fractures in elders

Zoledronic acid and denosumab proved to be as effective as teriparatide to prevent fractures in elders Zoledronic acid and denosumab proved to be as effective as teriparatide to prevent fractures in elders
Zoledronic acid and denosumab proved to be as effective as teriparatide to prevent fractures in elders Zoledronic acid and denosumab proved to be as effective as teriparatide to prevent fractures in elders

What's new?

Zoledronic acid and denosumab may be ideal choices for hip fracture prevention in elders.

In a recent comparative study between the three most acceptable treatments for osteoporosis, denosumab and zoledronic acid (ZA) was found to be as effective as teriparatide for the prevention of hip fractures in frail elderly.A.R. Zullo et al. evaluated the comparative efficacy of denosumab, teriparatide and ZA in elderly patients, given their limited evidence for fracture prevention in elderly adults.

In this national retrospective cohort study, novel parenteral ZA, denosumab, and teriparatide usage was examined in ≥ 65 years old patients (mean age 85 years; 90% female patients, and 68% had at least moderate functional impairment). The inverse probability weighted competing risk regression models were helpful in distinguishing amongst the study groups with reference to teriparatide.

Out of total 2019 patients, denosumab, teriparatide and ZA was initiated in 1046, 578 and 395 patients, respectively. Over 1.5 years’ follow-up, hip fracture was reported by 72 patients (3.6%) and 1100 patients (54.5%) died. The use of denosumab was linked with a 46% lower hip fracture risk than teriparatide. No such difference was perceived in case of ZA.

Although denosumab and ZA may be as useful as teriparatide; these are expected to be ideal non-oral therapies for hip fractures considering their lower cost and ease of administration in elderly population, concluded the study authors.

Source:

Osteoporosis International

Article:

Comparative effectiveness of denosumab, teriparatide, and zoledronic acid among frail older adults: a retrospective cohort study

Authors:

‪A.R. Zullo et al.

Comments (0)

You want to delete this comment? Please mention comment Invalid Text Content Text Content cannot me more than 1000 Something Went Wrong Cancel Confirm Confirm Delete Hide Replies View Replies View Replies en ru ua
Try: